ZA738479B - Products showing gastric acid antisecretory activity - Google Patents

Products showing gastric acid antisecretory activity

Info

Publication number
ZA738479B
ZA738479B ZA738479A ZA738479A ZA738479B ZA 738479 B ZA738479 B ZA 738479B ZA 738479 A ZA738479 A ZA 738479A ZA 738479 A ZA738479 A ZA 738479A ZA 738479 B ZA738479 B ZA 738479B
Authority
ZA
South Africa
Prior art keywords
gastric acid
products showing
antisecretory activity
acid antisecretory
showing gastric
Prior art date
Application number
ZA738479A
Other languages
English (en)
Inventor
G Cerbai
W Murmann
Original Assignee
Guidotti & C Spa Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guidotti & C Spa Labor filed Critical Guidotti & C Spa Labor
Publication of ZA738479B publication Critical patent/ZA738479B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes
    • C07D221/12Phenanthridines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA738479A 1972-11-06 1973-11-05 Products showing gastric acid antisecretory activity ZA738479B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT3131972 1972-11-06

Publications (1)

Publication Number Publication Date
ZA738479B true ZA738479B (en) 1974-11-27

Family

ID=11233456

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA738479A ZA738479B (en) 1972-11-06 1973-11-05 Products showing gastric acid antisecretory activity

Country Status (7)

Country Link
JP (1) JPS49133376A (fr)
BE (1) BE806984A (fr)
DE (1) DE2355084A1 (fr)
FR (1) FR2205333A1 (fr)
IL (1) IL44001A0 (fr)
NL (1) NL7315191A (fr)
ZA (1) ZA738479B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089426B1 (fr) * 1979-07-12 1986-06-11 A.H. Robins Company, Incorporated Acides 2-amino-6-biphénylacétiques
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US20020022636A1 (en) * 1997-09-03 2002-02-21 Jia-He Li Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout
NZ547193A (en) * 2003-12-05 2010-03-26 Janssen Pharmaceutica Nv 6-Substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
JP5399905B2 (ja) * 2006-09-01 2014-01-29 センワ バイオサイエンシズ インコーポレイテッド セリン−トレオニンタンパク質キナーゼおよびparp調節因子

Also Published As

Publication number Publication date
BE806984A (fr) 1974-03-01
NL7315191A (fr) 1974-05-08
DE2355084A1 (de) 1974-05-16
JPS49133376A (fr) 1974-12-21
FR2205333A1 (en) 1974-05-31
IL44001A0 (en) 1974-05-16

Similar Documents

Publication Publication Date Title
IL40521A (en) 1-heterocyclyl-3-indolealkanoic acid derivatives
MY7700132A (en) Prostanoic acid derivatives
ZA738479B (en) Products showing gastric acid antisecretory activity
ZA737566B (en) Fluidized bed process
ZA737357B (en) Prostanoic acid derivatives
ZA734687B (en) Succinic acid derivatives
IE37237L (en) Pyrroleacetic acid derivatives
ZA725578B (en) Conveyor system
GB1448264A (en) Conveyors
PH12447A (en) 6-aminopenicillanic acid preparation
CS188898B2 (en) Conveyor
ZA735534B (en) Catalytic process
MY7600270A (en) Thiocarbamic acid derivatives
ZA729096B (en) Acaricides
GB1448699A (en) Conveyor system
GB1448664A (en) Conveyors
ZA723158B (en) 2-p-nitro-or p-chlorobenzamidoaceto-hydroxamic acid
PH9332A (en) 2-chloroethanephosphonic acid derivatives
ZA739401B (en) Conversion process
GB1405794A (en) Alpha-thioacetic acid derivatives
GB1446555A (en) Conveyors
GB1446317A (en) Conveyors
ZA737591B (en) 13-bromo-lysergic acid compounds
AU5920273A (en) Alpha-phenyl-fatty acid compounds
ZA721129B (en) 5-n-pyrrylsalicylic acid